Skip to main content
COR
NYSE Life Sciences

Cencora Boosts FY26 Adjusted EPS Outlook to $17.70-$17.90

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$267.77
Mkt Cap
$51.644B
52W Low
$244.82
52W High
$377.54
Market data snapshot near publication time

summarizeSummary

Cencora has raised its fiscal year 2026 adjusted EPS guidance to a new range of $17.70 to $17.90. This specific update follows the company's Q2 earnings report on May 6, where it had previously announced a general raise in its full-year EPS guidance. The upward revision signals improved financial performance expectations and management's confidence in the company's outlook.

At the time of this announcement, COR was trading at $267.77 on NYSE in the Life Sciences sector, with a market capitalization of approximately $51.6B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed COR - Latest Insights

COR
May 21, 2026, 5:11 PM EDT
Source: Reuters
Importance Score:
8
COR
May 21, 2026, 4:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
COR
May 06, 2026, 2:41 PM EDT
Filing Type: 10-Q
Importance Score:
7
COR
May 06, 2026, 7:39 AM EDT
Source: Reuters
Importance Score:
8
COR
May 06, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
COR
Mar 23, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
COR
Mar 23, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
COR
Mar 17, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
7
COR
Feb 18, 2026, 7:34 AM EST
Filing Type: 8-K
Importance Score:
9
COR
Feb 10, 2026, 5:26 PM EST
Filing Type: FWP
Importance Score:
8